Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:30 PM UTC
| NCT Number | NCT06991556 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 17, 2026: Clinical trial NCT06991556 is currently recruiting participants. This phase2 study for prostate cancer is actively seeking new participants at 21 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06991556 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06991556 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.